Cognition Therapeutics, Inc.
CGTX
$1.01
-$0.03-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.78M | -19.58M | -23.49M | -27.99M | -32.99M |
| Total Depreciation and Amortization | 245.00K | 251.00K | 228.00K | 238.00K | 247.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.55M | 1.88M | 2.13M | 2.26M | 2.64M |
| Change in Net Operating Assets | -2.71M | -2.80M | -3.46M | -4.05M | -624.00K |
| Cash from Operations | -17.68M | -20.25M | -24.59M | -29.53M | -30.73M |
| Capital Expenditure | -20.00K | -- | -- | -1.00K | -1.00K |
| Sale of Property, Plant, and Equipment | 9.00K | 9.00K | 9.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.00K | 9.00K | 9.00K | -1.00K | -1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -344.00K | -348.00K | -353.00K | -474.00K | -618.00K |
| Issuance of Common Stock | 43.78M | 37.92M | 39.33M | 49.24M | 15.24M |
| Repurchase of Common Stock | -288.00K | -282.00K | -164.00K | -87.00K | -866.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.25M | -2.25M | -2.25M | -1.33M | 0.00 |
| Cash from Financing | 40.90M | 35.04M | 36.57M | 47.35M | 13.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.21M | 14.80M | 11.99M | 17.81M | -16.98M |